Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5391-5397

  Zeis, Matthias ^a   Siegel, Sandra ^a   Wagner, Andreas ^b   Schmitz, Marc ^c   Marget, Matthias ^b   Kühl Burmeister, Rita ^b   Adamzik, Ilse ^b   Kabelitz, Dieter ^b   Dreger, Peter ^a   Schmitz, Norbert ^a   Heiser, Axel ^b  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; SURVIVIN; TUMOR VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; GENETIC TRANSFECTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; TUMOR REJECTION; TUMOR RESISTANCE; VACCINATION;

EID: 0038528582     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5391     Document Type: Article

References (19)

1. Ambrosini, G., C. Adida, and D. C. Altieri. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917.
2. Altieri, D. C. 2003. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 1:46.
3. + hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle 5:322.
4. Gianani, R., E. Jarboe, D. Orlicky, M. Frost, J. Bobak, R. Lehner, and K. R. Shroyer. 2001. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum. Pathol. 32:119.
5. Velculescu, V. E., S. L. Madden, L. Zhang, A. E. Lash, J. Yu, C. Rago, A. Lal, C. J. Wang, G. A. Beaudry, K. M. Cirello, et al. 1999. Analysis of human transcriptomes. Nat. Genet. 23:387.
6. Choi, N., M. Baumann, M Flentjie, P. Kellokumpu-Lehtinen, S. Senan, N. Zamboglou, and P. Kosmidis. 2001. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer 1:43.
7. Adida, C., C. Recher, E. Raffoux, M. T. Daniel, A. L. Taksin, P. Rousselot, F. Sigaux, L. Degos, D. C. Altieri, and H. Dombret. 2000. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br. J. Haematol. 111:196.
8. Adida, C., C. Haioun, P. Gaulard, E. Lepage, P. Morel, J. Briere, H. Dombret, F. Reyes, J. Diebold, C. Gisselbrecht, et al. 2000. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96:1921.
9. Tanaka, K., S. Iwamoto, G. Gon T. Nohara, M. Iwamoto, and N. Tanigawa. 2000. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 1:127.
10. + T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res. 60:4845.
11. Hirohashi, Y., T. Torigoe, A. Maeda, Y. Nabeta, K. Kamiguchi, T. Sato, J. Yoda, H. Ikeda, K. Hirata, N. Yamanaka, and N. Sato. 2002. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin. Cancer Res. 6:1731.
12. Andersen, M. H., L. Pedersen, B. Capeller, E. B. Brocker, J. C. Becker, and P. thor Straten. 2001. Spontaneous cytotoxic T-cell responses against survivinderived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res. 61:5964.
13. Andersen, M. H., L. O. Pedersen, J. C. Becker, and P. T. Straten. 2001. Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Cancer Res. 61:869.
14. Carter, B. Z., M. Milella, D. C. Altieri, and M. Andreeff. 2001. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97:2784.
15. Moriai, R., K. Asanuma, D. Kobayashi, T. Yajima, A. Yagihashi, M. Yamada, and N. Watanabe. 2001. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res. 21:595.
16. Feuerstein, B., T. G. Berger, C. Maczek, C. Roder, D. Schreiner, U. Hirsch, I. Haendle, W. Leisgang, A. Glaser, O. Kuss, et al. 2000. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J. Immunol. Methods 245:15.
17. Heiser, A., M. A. Maurice, D. R. Yancey, D. M. Coleman, P. Dahm, and J. Vieweg. 2001. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res. 61:3388.
18. Zeis, M., H. Frenzke, N. Schmitz, L. Uharek, and J. Steinmann. 2002. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice. Bone Marrow Transplant. 29:213.
19. Nair, S. K., A. Heiser, D. Boczkowski, A. Majumdar, M. Naoe, J. S. Lebkowski, J. Vieweg, and E. Gilboa. 2000. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat. Med. 6:1011.